{"id":162119,"title":"An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics, CCDR 50(10) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T05:03:30.954000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/innovative-tool-prioritize-assessment-investigational-covid-19-therapeutics.html?wbdisable=true","snippet":"An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics, CCDR 50(10) - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the…","rawSnapshotUrl":"/api/snapshots/raw/162119","browseUrl":"https://replay.healtharchive.ca/job-1/20250419050330/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/innovative-tool-prioritize-assessment-investigational-covid-19-therapeutics.html?wbdisable=true#ha_snapshot=162119","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}